Clinical Trial Update: A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical study to evaluate the investigational drug DNTH103 in adults with Multifocal Motor Neuropathy is currently recruiting. The sponsor is Dianthu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Motor Neuropathy

Drugs mentioned

• DNTH103

Snippet

Sponsor: Dianthus Therapeutics | Conditions: Multifocal Motor Neuropathy | Phase 2 | Status: RECRUITING